Latest Vivesto News & Updates
See the latest news and media coverage for Vivesto. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish oncology drug development company
vivesto.com- Headquarters
- Stockholm, Sweden
- Founded year
- 1999
- Company type
- Public company
- Number of employees
- 2–30
Latest news about Vivesto
Company announcements
-
Vivesto proposes reverse share split and capital reduction
The Board proposes consolidating 100 shares into 1 and reducing share capital from SEK 110,713,691 to SEK 11,071,369 for AGM on May 7, 2026.
-
Vivesto announces first dogs dosed in Cantrixil PK/toxicology study
The study supports development for human AML and dog cancer pilot. Early observations show good tolerability. Results expected summer 2026.
-
Vivesto announces new total shares and votes
Rights issue increases shares by 538,043,455; set-off issue by 31,050,000. Total now 1,107,136,910.
-
Vivesto resolves directed share issue to guarantors
The Board issues 31,050,000 shares at SEK 0.10 each, offsetting guarantors' claims from the rights issue. Share capital increases, diluting by 2.8%.
Media coverage
-
Vivesto proposes reverse stock split and share capital reduction | MarketScreener
The Board of Directors of the research company Vivesto proposes that the Annual General Meeting on May 7 resolve on a reverse stock split, whereby...
-
Vivesto AB: First dogs dosed in Vivesto's PK/toxicology study with Cantrixil
Solna, Sweden, March 13, 2026 - Vivesto AB, an oncology-focused development company, today announces that the first dogs have been dosed in the company's ongoing...
-
New number of shares and votes in Vivesto
Vivesto AB ("Vivesto" or the "Company") has, as previously announced, completed a rights issue of shares and a directed set-off issue of shares to certain...
-
Vivesto resolves on a fully secured rights issue of approximately SEK 53.8 million, subject to approval by an Extraordinary General Meeting
The Board of Directors of Vivesto AB ("Vivesto" or the "Company") has today resolved on a new issue of shares with preferential rights for existing...
Track Vivesto and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Vivesto competitors & trending companies
Browse news for competitors to Vivesto and other trending companies.
Medivir
Allarity Therapeutics
Sprint Bioscience
Novakand Pharma
Spago Nanomedical
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy